Sakano M, Tomita Y, Kanazawa T, Ishibashi S, Ikeda M, Oshita H
Front Oncol. 2024; 14:1459940.
PMID: 39723384
PMC: 11668648.
DOI: 10.3389/fonc.2024.1459940.
Tang Y, Shi T, Lin S, Fang T
Front Oncol. 2024; 14:1450603.
PMID: 39678502
PMC: 11638059.
DOI: 10.3389/fonc.2024.1450603.
Wang L, Du J, Sun H
Int J Public Health. 2024; 69:1607315.
PMID: 39170811
PMC: 11335483.
DOI: 10.3389/ijph.2024.1607315.
Lopez-Gomez M, Morales M, Fuerte R, Munoz M, Delgado-Lopez P, Gomez-Cerezo J
World J Gastroenterol. 2024; 30(29):3479-3487.
PMID: 39156503
PMC: 11326089.
DOI: 10.3748/wjg.v30.i29.3479.
Fang P, Zhou J, Liang Z, Yang Y, Luan S, Xiao X
J Thorac Dis. 2024; 16(7):4460-4473.
PMID: 39144298
PMC: 11320261.
DOI: 10.21037/jtd-24-187.
The role of FDG PET/CT radiomics in the prediction of pathological response to neoadjuvant treatment in patients with esophageal cancer.
Eifer M, Peters-Founshtein G, Yoel L, Pinian H, Steiner R, Klang E
Rep Pract Oncol Radiother. 2024; 29(2):211-218.
PMID: 39143975
PMC: 11321767.
DOI: 10.5603/rpor.99906.
Role of ursolic acid in preventing gastrointestinal cancer: recent trends and future perspectives.
Chauhan A, Pathak V, Yadav M, Chauhan R, Babu N, Chowdhary M
Front Pharmacol. 2024; 15:1405497.
PMID: 39114347
PMC: 11303223.
DOI: 10.3389/fphar.2024.1405497.
Cholelithiasis and cholecystectomy increase the risk of gastroesophageal reflux disease and Barrett's esophagus.
Huang Y, Cai Y, Chen Y, Zhu Q, Feng W, Jin L
Front Med (Lausanne). 2024; 11:1420462.
PMID: 39091288
PMC: 11292949.
DOI: 10.3389/fmed.2024.1420462.
Endoscopic Advances in the Diagnosis and Management of Gastroesophageal Reflux Disease.
Loganathan P, Gajendran M, Perisetti A, Goyal H, Mann R, Wright R
Medicina (Kaunas). 2024; 60(7).
PMID: 39064549
PMC: 11278532.
DOI: 10.3390/medicina60071120.
Analysis of Molecular Genetic Variants of Lgals4 in Esophageal Cancer: A Preliminary Report.
Kaur S, Devgan R, Singh J, Kalia N, Singh J, Kaur M
Biochem Genet. 2024; .
PMID: 38605207
DOI: 10.1007/s10528-024-10780-y.
Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional Regulation.
ONeill J, Mayordomo M, Mitulovic G, Al Shboul S, Bedran G, Faktor J
Mol Cell Proteomics. 2024; 23(6):100764.
PMID: 38604503
PMC: 11245951.
DOI: 10.1016/j.mcpro.2024.100764.
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma.
Hirose T, Yamamoto S, Honma Y, Yokoyama K, Hirano H, Okita N
Esophagus. 2024; 21(3):328-335.
PMID: 38467986
PMC: 11199255.
DOI: 10.1007/s10388-024-01050-2.
PSMA7 promotes the malignant proliferation of esophageal cancer.
Jiao Q, Wang Y, Zhang A, Liu Q, Zhou Q
Heliyon. 2024; 10(1):e23173.
PMID: 38173490
PMC: 10761361.
DOI: 10.1016/j.heliyon.2023.e23173.
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.
Lonie J, Brosda S, Bonazzi V, Aoude L, Patel K, Brown I
Front Immunol. 2023; 14:1220129.
PMID: 37965317
PMC: 10642165.
DOI: 10.3389/fimmu.2023.1220129.
IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma.
Muthupalani S, Annamalai D, Feng Y, Ganesan S, Ge Z, Whary M
Sci Rep. 2023; 13(1):12732.
PMID: 37543673
PMC: 10404242.
DOI: 10.1038/s41598-023-39907-8.
Esophageal organoids: applications and future prospects.
Liu H, Wang X
J Mol Med (Berl). 2023; 101(8):931-945.
PMID: 37380866
DOI: 10.1007/s00109-023-02340-5.
Gastroesophageal adenocarcinoma metastasizing to the chest wall: A case report and mini‑review of the literature.
Ali R, Ghalib Hawramy O, Kakamad F, Hamasaeed D, Tahir S, Ismaeil D
Med Int (Lond). 2023; 3(3):31.
PMID: 37359054
PMC: 10288431.
DOI: 10.3892/mi.2023.91.
Phase I study of cisplatin and nanoparticle albumin-bound-paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma.
Jiang H, Li Q, Chen B, Xi M, Makelike K, Liu S
Cancer Med. 2023; 12(14):15187-15198.
PMID: 37334881
PMC: 10417080.
DOI: 10.1002/cam4.6205.
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy.
Gensthaler L, Jomrich G, Brugger J, Kollmann D, Paireder M, Bologheanu M
Langenbecks Arch Surg. 2023; 408(1):227.
PMID: 37280384
PMC: 10244274.
DOI: 10.1007/s00423-023-02938-w.
Should All Patients with Barrett's Esophagus Receive Ablation?.
Shafa S, Carroll J
Curr Gastroenterol Rep. 2023; 25(6):115-121.
PMID: 37204654
DOI: 10.1007/s11894-023-00869-6.